GSK3B and Alzheimer disease: In this work, ICV-STZ group increased the expression of p-ERK1/2 and downregulated p-GSK-3β (Ser9), beside reducing the hippocampal content of p-CREB (Ser133) and BDNF, thus participating in neuronal death and AD pathogenesis.